Role of Nitric Oxide in Pathogenesis of Prehepatic Portal Hypertension

施斌,朱樑,张忠兵,谢渭芬,张兴荣,曹银祥,李齐根,沈健伟
DOI: https://doi.org/10.3321/j.issn:0258-879x.2002.11.013
2002-01-01
Abstract:Objective: To ascertain the role of nitric oxide (NO) in the pathogenesis of prehepatic portal hypertension. Methods: The models of prehepatic portal hypertension were established in SD rats by means of partial portal vein ligation (PVL). The plasma levels of NO and nitric oxide synthase (NOS) in portal veins were detected with nitric reductase and colorimetry. The rats were divided into normal, sham operation (SO) and PVL group. SO and PVL rats were divided into subgroups according to different time after operations. The changes of hemodynamic indexes in rats were measured; The effects of L-N~G-nitro-arginine methyl ester (L-NAME), an inhibitor of NO biosynthesis were investigated in portal hypertension rats. Results: NO and NOS levels and hemodynamic indexes after SO were not markedly different from those of normal groups. Significant increases were noted in NO, NOS levels and portal venous pressure (PVP), portal vascular resistance (PVR) at different time after PVL compared with normal controls (P < 0.05), whereas mean arterial pressure (MAP) and splanchnic vascular resistance (SVR) were significantly decreased (P < 0.05) and portal venous flow (PVF) was not markedly different from those of normal controls. In addition, the plasma NO levels were correlated with PVP, PVF, SVR and MAP. Administration of L-NAME significantly decreased PVP, PVR and increased SVR, MAP in portal hypertensive rats. Conclusion: The portal hypertensive rats are in hyperdynamic circulatory state. NO plays a key role in the hemodynamic changes of PVL rats and the induction of prehepatic portal hypertension.
What problem does this paper attempt to address?